• There are no items in your cart

ASTM D 4774 : 2011 : R2017

Current
Current

The latest, up-to-date edition.

Standard Specification for User Applied Drug Labels in Anesthesiology (Withdrawn 2022)
Available format(s)

Hardcopy , PDF

Language(s)

English

Published date

02-28-2018

CONTAINED IN VOL. 15.10, 2018 Defines the size, color and pattern, and type used on labels applied to unlabeled syringes filled by the users or their agents to identify the drug content.

1.1This specification covers the size, color, pattern, and type used on labels applied to unlabeled syringes filled by the users or their agents to identify the drug content. This specification is not intended to cover labels applied by the drug manufacturer.

FIG. 1Standard Background Colors for User Applied Syringe Drug Labels

Standard Background Colors for User Applied Syringe Drug LabelsStandard Background Colors for User Applied Syringe Drug Labels

FIG. 2 Label for an Antagonist Drug

 Label for an Antagonist Drug Label for an Antagonist Drug

FIG. 3 Reversed Plate Printing Used to Identify "SUCCINYLcholine," "EPINEPHrine," and Beta Blockers, "ESMOlol," "LABATolol," and "METOprolol"

 Reversed Plate Printing Used to Identify  Reversed Plate Printing Used to Identify

FIG. 4Optional Printing

Optional PrintingOptional Printing

Note—Bold upper-case type is shown for first or first and second syllables of the drug name.

FIG. 5 Drug Name and Dosage

 Drug Name and Dosage Drug Name and Dosage

FIG. 6 Alternative Label Showing Concentration in Percent and mg/mL

 Alternative Label Showing Concentration in Percent and mg/mL Alternative Label Showing Concentration in Percent and mg/mL

1.2The values stated in SI units are to be regarded as the recommended values. The use of inch-pound system values, not being exact equivalents, may result in nonconformance with the standard.

1.3This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety, health, and environmental practices and determine the applicability of regulatory limitations prior to use.

1.4This international standard was developed in accordance with internationally recognized principles on standardization established in the Decision on Principles for the Development of International Standards, Guides and Recommendations issued by the World Trade Organization Technical Barriers to Trade (TBT) Committee.

Committee
F 02
DocumentType
Standard
Pages
3
ProductNote
Reconfirmed 2017
PublisherName
American Society for Testing and Materials
Status
Current
Supersedes

ASTM D 6398 : 2008 : R2014 Standard Practice to Enhance Identification of Drug Names on Labels (Withdrawn 2022)

ASTM D 996 : 2016 : REDLINE Standard Terminology of Packaging and Distribution Environments
ASTM D 996 : 2010 Standard Terminology of Packaging and Distribution Environments

View more information
US$66.00
Excluding Tax where applicable

Access your standards online with a subscription

Features

  • Simple online access to standards, technical information and regulations.

  • Critical updates of standards and customisable alerts and notifications.

  • Multi-user online standards collection: secure, flexible and cost effective.